Business
Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective...
NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to...
NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications to assist in diagnosing cancer, today announced it is working with Visiopharm, an artificial intelligence (AI)-driven...
Xtalks: Featured speaker from Proscia will share real-world examples and use cases during free event. TORONTO, ONTARIO, CANADA (PRWEB) MAY 01, 2023 Preclinical research and development (R&D) centers around workflows that generate more...
Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding...
Exeter, England, April 19th 2023 — Diagnexia UK Limited, owned by Deciphex, is the UK's fastest-growing pathology diagnostics service provider. Today, the company proudly celebrated the launch of its expanded facility at Exeter Science Park....
